Medtronic PLC Net Debt Over Time
| MDT Stock | USD 86.21 1.47 1.73% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medtronic PLC Performance and Medtronic PLC Correlation. Medtronic |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.356 | Earnings Share 3.27 | Revenue Per Share 24.709 | Quarterly Revenue Growth 0.028 | Return On Assets 0.0442 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Debt Analysis
Compare Medtronic PLC and related stocks such as Edwards Lifesciences Corp, Abbott Laboratories, and Boston Scientific Corp Net Debt Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EW | 400 M | (20.8 M) | (121.6 M) | 172.7 M | (55.7 M) | (118.5 M) | (107.8 M) | 218.1 M | (120.3 M) | (500.3 M) | (488.3 M) | (172.5 M) | (77.7 M) | (449.1 M) | (426.6 M) |
| ABT | 128.4 M | 8.6 B | 9.7 B | 3.1 B | 3.8 B | 4 B | 3.4 B | 18.5 B | 15.7 B | 15 B | 12.8 B | 9.2 B | 7.8 B | 9 B | 6.1 B |
| BSX | 19.3 M | 4 B | 4 B | 4 B | 3.7 B | 5.4 B | 5.3 B | 5.4 B | 6.9 B | 10.1 B | 7.8 B | 7.5 B | 8.4 B | 8.6 B | 9.1 B |
| ZBH | 345.5 M | 951 M | 936.6 M | 592.2 M | 342.2 M | 10.1 B | 10.6 B | 9.6 B | 8.4 B | 7.6 B | 7.3 B | 6.7 B | 5.3 B | 5.6 B | 3.7 B |
| SYK | (7.8 M) | 846 M | 351 M | 1.4 B | 1.5 B | (126 M) | 3.4 B | 4 B | 4.9 B | 5.9 B | 10.3 B | 9.5 B | 11.2 B | 10 B | 10.5 B |
| DXCM | (13.9 M) | (2.6 M) | (1.1 M) | (36.4 M) | (67.2 M) | (83.8 M) | (88.5 M) | (113.9 M) | (126.7 M) | 699.5 M | 1 B | 769.2 M | 1.4 B | 2 B | 2.1 B |
| PODD | (17 M) | 14.6 M | 60.9 M | (28 M) | 23.4 M | 54.8 M | 34.5 M | 126.1 M | 303 M | 511.8 M | 96.1 M | 457.2 M | 727.1 M | 711.6 M | 747.2 M |
| TNDM | 4.2 M | 4.2 M | (13 M) | (95 M) | (1.7 M) | (13.4 M) | 34.3 M | 62.8 M | (41.8 M) | (30.8 M) | 133.7 M | 243.5 M | 247.4 M | 356.8 M | 374.6 M |
| ALGN | (6.8 M) | (240.7 M) | (306.4 M) | (243 M) | (199.9 M) | (167.7 M) | (389.3 M) | (449.5 M) | (636.9 M) | (507 M) | (896.4 M) | (996.7 M) | (815.1 M) | (810.8 M) | (770.3 M) |
Medtronic PLC and related stocks such as Edwards Lifesciences Corp, Abbott Laboratories, and Boston Scientific Corp Net Debt description
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.My Equities
My Current Equities and Potential Positions
| Medtronic PLC | MDT |
| Classification | Medical Equipment |
| Location | Ireland |
| Exchange | New York Stock Exchange |
USD 86.21
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.